Rxo (RXO) Depreciation & Amortization (CF) (2021 - 2026)

Rxo (RXO) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $26.0 million in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 18.75% year-over-year to $26.0 million; the trailing twelve-month figure through Mar 2026 stood at $110.0 million (up 6.8% YoY), and the FY2025 full-year result was $116.0 million, up 33.33% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $26.0 million, down from $28.0 million in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $33.0 million in Q4 2024 and bottomed at $15.0 million in Q4 2023.
• The 5-year median for Depreciation & Amortization (CF) is $21.0 million (2022), against an average of $22.5 million.
• The widest annual swing landed in 2023, when Depreciation & Amortization (CF) plunged 30.43%; it then soared 120.0% in 2024.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $21.0 million in 2022, then decreased by 28.57% to $15.0 million in 2023, then surged by 120.0% to $33.0 million in 2024, then fell by 15.15% to $28.0 million in 2025, then decreased by 7.14% to $26.0 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $26.0 million (Q1 2026), $28.0 million (Q4 2025), and $26.0 million (Q3 2025), per Business Quant data.

Peer Comparison